Selective anti-cancer activity against melanoma cells using 3-O-acetyl-β-boswellic acid-loaded 3D-Printed scaffold

Fatemeh Jamshidi-adegani, Saeid Vakilian, Sulaiman Al-Hashmi*, Juhaina Al-Kindi, Najeeb Ur Rehman, Yaqeen Al-Sinani, Shokoofeh Ghaemi, Khurshid Alam, Muhammad U. Anwar, Rene Csuk, Ahmed Al-Harrasi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

This study aimed to develop a local 3 D-printed bioactive graft using poly-caprolacton (PCL) as a drug carrier and 3-O-acetyl-β-boswellic acid (β-ABA) as an anticancer compound. β-ABA-loaded 3 D-printed scaffold was fabricated and physically characterized. The results indicated more desirable mechanical and physical properties of the β-ABA-loaded PCL mat in comparison with the PCL scaffold. Following sustained release of β-ABA, the β-ABA-loaded PCL scaffold revealed selective cytotoxic activity against melanoma cells, while the PCL + ABA with the bolus delivery of β-ABA was toxic against fibroblast cells. Followed by the induction of apoptosis in melanoma cells at the gene level, the result of the western blot showed that the β-ABA-loaded scaffold significantly up-regulated P53 and down-regulated BCL2, with an increment in the ratio of Bax/BCL2. The selective anti-cancer properties of β-ABA-loaded 3 D printed scaffold against melanoma cells indicated that this scaffold could be potentially used as a bioactive graft to improve the melanoma treatment.

Original languageEnglish
Pages (from-to)2049-2054
Number of pages6
JournalNatural Product Research
Volume37
Issue number12
DOIs
Publication statusPublished - Jun 2023

Keywords

  • 3D-printing
  • BCL2
  • boswellic acid
  • melanoma
  • p53
  • skin tissue engineering
  • sustained delivery
  • Humans
  • Melanoma/drug therapy
  • Proto-Oncogene Proteins c-bcl-2
  • Printing, Three-Dimensional

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Plant Science
  • Organic Chemistry

Cite this